Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-186908
Filing Date
2008-08-29
Accepted
2008-08-28 17:56:36
Documents
10
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED JUNE 30, 2008 d10k.htm 10-K 916938
2 LOAN AGREEMENT WITH BANK OF AMERICA, N.A. DATED JUNE 6, 2008 dex1044.htm EX-10.44 197852
3 LICENSE AND COLLABORATION AGREEMENT WITH IMMUNOMEDICS, INC AND NYCOMED GMBH dex1045.htm EX-10.45 546682
4 SUBSIDIARIES OF THE COMPANY dex211.htm EX-21.1 2099
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ERNST & YOUNG LLP dex231.htm EX-23.1 1715
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302(A) dex311.htm EX-31.1 5937
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302(A) dex312.htm EX-31.2 6017
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 dex321.htm EX-32.1 2849
9 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 dex322.htm EX-32.2 2889
10 GRAPHIC g89216img1.jpg GRAPHIC 55264
  Complete submission text file 0001193125-08-186908.txt   1760660
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-12104 | Film No.: 081046554
SIC: 2835 In Vitro & In Vivo Diagnostic Substances